Li Wan
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biomaterials top 10%
- Nanocomposite Films for Food Packaging
Papers in
-
- Natural product bioactivities and synthesis 3
-
- Traditional Chinese Medicine Analysis 6
- Co-authors
- Liwen Ren (1 shared paper)Guanhua Du (1 shared paper)Weiqi Fu (1 shared paper)Jinhua Wang (1 shared paper)Jie Yi (1 shared paper)Jinyi Liu (1 shared paper)Xiangjin Zheng (1 shared paper)Sha Li (1 shared paper)
- Journals
- International Journal of Biological Macromolecules (3 papers)Journal of Ethnopharmacology (3 papers)Journal of Separation Science (2 papers)Chemical Engineering Journal (2 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Li Wan
49 papers receiving 1.2k citations
Li Wan's Hit Papers
Peers
Comparison fields: 5 of 117
- Cancer Research 239
- Biomaterials 143
- Molecular Biology 563
- Complementary and alternative medicine 53
- Molecular Medicine 32
Countries citing papers authored by Li Wan
This map shows the geographic impact of Li Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Wan more than expected).
Fields of papers citing papers by Li Wan
This network shows the impact of papers produced by Li Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Wan. The network helps show where Li Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The biology, function, and applications of exosomes in cancer Hit paper breakdown → | 2021 | 419 |
| 2 | The strategies and techniques of drug discovery from natural products Hit paper breakdown → | 2020 | 207 |
| 3 | 2019 | 112 | |
| 4 | 2021 | 45 | |
| 5 | 2022 | 41 | |
| 6 | 2014 | 37 | |
| 7 | 2022 | 37 | |
| 8 | 2018 | 32 | |
| 9 | 2021 | 32 | |
| 10 | 2016 | 23 | |
| 11 | 2012 | 21 | |
| 12 | 2024 | 17 | |
| 13 | 2024 | 17 | |
| 14 | 2024 | 15 | |
| 15 | 2024 | 14 | |
| 16 | 2020 | 13 | |
| 17 | 2024 | 12 | |
| 18 | 2024 | 12 | |
| 19 | 2020 | 10 | |
| 20 | 2023 | 10 |
About Li Wan
Li Wan is a scholar working on Molecular Biology, Complementary and alternative medicine, Pharmacology, Civil and Structural Engineering and Oncology, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (6 papers), Pharmacological Effects of Natural Compounds (5 papers), Thermal Radiation and Cooling Technologies (4 papers), Urban Heat Island Mitigation (4 papers), Building Energy and Comfort Optimization (3 papers), Computational Drug Discovery Methods (3 papers), Chromatography in Natural Products (3 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Cancer Research (239 citations), Biomaterials (143 citations), Molecular Biology (563 citations), Complementary and alternative medicine (53 citations) and Molecular Medicine (32 citations). Li Wan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Liwen Ren, Guanhua Du, Weiqi Fu, Jinhua Wang, Jie Yi, Jinyi Liu, Xiangjin Zheng, Sha Li, Yihui Yang and Tianyi Yuan. Their work appears in journals such as International Journal of Biological Macromolecules, Journal of Ethnopharmacology, Journal of Separation Science, Chemical Engineering Journal and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.